4//SEC Filing
ZIOPHARM ONCOLOGY INC 4
Accession 0001209191-17-000996
$TCRTCIK 0001107421operating
Filed
Jan 3, 7:00 PM ET
Accepted
Jan 4, 4:41 PM ET
Size
10.2 KB
Accession
0001209191-17-000996
Insider Transaction Report
Form 4
Cooper Laurence James Neil
Chief Executive Officer
Transactions
- Tax Payment
Common Stock
2016-12-31$5.35/sh−17,292$92,512→ 1,209,291 total - Award
Common Stock
2016-12-30+212,250→ 1,226,583 total
Footnotes (2)
- [F1]70,750 shares vest on each of 12/30/2017, 12/30/2018 and 12/30/2019.
- [F2]Represents shares withheld to satisfy withholding tax obligations upon the vesting of restricted stock grants.
Issuer
ZIOPHARM ONCOLOGY INC
CIK 0001107421
Entity typeoperating
IncorporatedDE
Related Parties
1- filerCIK 0001107421
Filing Metadata
- Form type
- 4
- Filed
- Jan 3, 7:00 PM ET
- Accepted
- Jan 4, 4:41 PM ET
- Size
- 10.2 KB